The maximum chemiluminescence intensity predicts severe neutropenia in gemcitabine-treated patients with pancreatic or biliary tract cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0843
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The maximum chemiluminescence intensity predicts severe neutropenia in gemcitabine-treated patients with pancreatic or biliary tract cancer ; day:14 ; month:9 ; year:2018 ; pages:1-8
Cancer chemotherapy and pharmacology ; (14.9.2018), 1-8
- Urheber
-
Goto, Koki
- Beteiligte Personen und Organisationen
-
Matsuyama, Ryusei
Suwa, Yusuke
Arisaka, Sayaka
Kadokura, Toshiaki
Sato, Mari
Mori, Ryutaro
Kumamoto, Takafumi
Taguri, Masataka
Endo, Itaru
SpringerLink (Online service)
- DOI
-
10.1007/s00280-018-3685-6
- URN
-
urn:nbn:de:101:1-2018102920490735016142
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Goto, Koki
- Matsuyama, Ryusei
- Suwa, Yusuke
- Arisaka, Sayaka
- Kadokura, Toshiaki
- Sato, Mari
- Mori, Ryutaro
- Kumamoto, Takafumi
- Taguri, Masataka
- Endo, Itaru
- SpringerLink (Online service)
Ähnliche Objekte (12)
Ultra-weak chemiluminescence
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer
A Cost-Effectiveness Analysis of Gemcitabine plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan
Chemiluminescence in organic chemistry
Electrogenerated chemiluminescence : protocols and applications
Chemiluminescence microarrays in analytical chemistry
Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer
Diagnostic and prognostic value of quantitative detection of antimitochondrial antibodies subtype M2 using chemiluminescence immunoassay in primary biliary cholangitis
Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer : a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme
Gemcitabine-based versusfluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
Ultra-weak chemiluminescence
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer
A Cost-Effectiveness Analysis of Gemcitabine plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan
Chemiluminescence in organic chemistry
Electrogenerated chemiluminescence : protocols and applications
Chemiluminescence microarrays in analytical chemistry
Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer
Diagnostic and prognostic value of quantitative detection of antimitochondrial antibodies subtype M2 using chemiluminescence immunoassay in primary biliary cholangitis
Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer : a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme
Gemcitabine-based versusfluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
Ultra-weak chemiluminescence
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer
A Cost-Effectiveness Analysis of Gemcitabine plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan
Chemiluminescence in organic chemistry
Electrogenerated chemiluminescence : protocols and applications
Chemiluminescence microarrays in analytical chemistry
Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer
Diagnostic and prognostic value of quantitative detection of antimitochondrial antibodies subtype M2 using chemiluminescence immunoassay in primary biliary cholangitis
Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer : a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme